This company seems to have been delisted
Reason: Merged with Cytocom
Source: https://www.biospace.com/article/releases/cytocom-and-cleveland-biolabs-announce-definitive-merger-agreement/
Reason: Merged with Cytocom
Source: https://www.biospace.com/article/releases/cytocom-and-cleveland-biolabs-announce-definitive-merger-agreement/
Cleveland BioLabs
CBLI
$4.25
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)
Categories
Revenue for Cleveland BioLabs (CBLI)
Revenue in 2020 (TTM): S$0.86 Million
According to Cleveland BioLabs 's latest financial reports the company's current revenue is S$0.84 Million. In 2019 the company made a revenue of S$1.49 Million a decrease over the revenue in the year 2018 that were of S$1.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cleveland BioLabs from 2004 to 2020
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2020 (TTM) | S$0.86 M | -41.89% |
| 2019 | S$1.49 M | -2.18% |
| 2018 | S$1.52 M | -41.58% |
| 2017 | S$2.61 M | -44.62% |
| 2016 | S$4.71 M | 29.92% |
| 2015 | S$3.63 M | -26.84% |
| 2014 | S$4.96 M | -56.39% |
| 2013 | S$11.37 M | 137.71% |
| 2012 | S$4.78 M | -59.38% |
| 2011 | S$11.78 M | -42.67% |
| 2010 | S$20.55 M | 6.87% |
| 2009 | S$19.23 M | 204.87% |
| 2008 | S$6.3 M | 133.12% |
| 2007 | S$2.7 M | 18.17% |
| 2006 | S$2.28 M | 50% |
| 2005 | S$1.52 M | 78.97% |
| 2004 | S$0.85 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | S$0.3 M | -64.23% | 🇺🇸 USA |
 | S$0.95 B | 112,767.14% | 🇺🇸 USA |
 | S$44.80 B | 5,289,830.08% | 🇺🇸 USA |
 | S$69.33 B | 8,185,807.24% | 🇨🇭 Switzerland |
 | S$64.74 B | 7,644,216.14% | 🇺🇸 USA |
 | S$64.29 B | 7,590,459.62% | 🇫🇷 France |
 | S$53.86 B | 6,359,172.88% | 🇬🇧 UK |
 | S$0.15 M | -81.48% | 🇺🇸 USA |
 | S$60.37 B | 7,128,691.69% | 🇺🇸 USA |